PFKFB4 and melanoma: To sum up, our study highlights important differences in mRNA splicing between PFKFB4 isoforms expressed in melanoma cells and provides information about isoforms that should be functionally validated to confirm their role in metabolic adaptation and cellular signaling of malignant melanoma cells, which maybe be crucial for carcinogenesis and response to anti-melanoma therapies.